Effect of zinc supplementationin diagnosed cases of 2019 novel coronavirus

Not Applicable

Recruiting

• Conditions: Covid_19.; Use this code when COVID-19 has been confirmed by laboratory testing irrespective of severity of clinical signs or symptoms. Use additional code, if desired, to identify pneumonia or other manifestations; U07.1

• Registration Number: IRCT20211112053046N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 November 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 140

Inclusion Criteria

Diagnosis of COVID-19 infection is subject to the approval of a specialist
Age 18 to 65 years

Exclusion Criteria

addict
Allergy to zinc
Pregnancy and lactation
Occurrence of special medical conditions
History of AIDS and chronic lung disease
History of corticosteroids and chemotherapy drugs in the past month
Use of drugs that affect metabolism
Use multivitamin supplements that are more than 10 mg per day

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
evel CRP. Timepoint: Measurement of reaction level _ thirty before the intervention and 14 days after starting zinc supplementation. Method of measurement: Enzyme-dependent immunosorbent assay kit.

Secondary Outcome Measures

Name	Time	Method
evel of neutrophil to lymphocyte ratio. Timepoint: Measurement of neutrophil to lymphocyte ratio level before intervention and 14 days after zinc supplementation. Method of measurement: Microscopic counting.